Table 1.

Proportion of patients with bullous pemphigoid exposed to oral prednisolone as presented in published studies, presented alongside dose and duration information

Publication	Country	Setting	Years	n	Treatment timing	Patients on oral prednisolone, %	Additional dose and duration detail
Balestri et al (2018)¹²	Italy	Clinic	2008–2012	53	Initial	96.2	Dose range: 0.5–0.75 mg/kg/day
Kremer et al (2017)¹³	Israel	Hospital	2008–2014	104	Initial	78.1	Mean dose: 57.3 mg/day (range 30–70 mg/day)
Zhang et al (2013)¹⁴	China	Hospital	2005–2010	94	Initial	85.0	Maximum dose: range 20–80 mg/day
Esmaili et al (2012)¹⁵	Iran	Hospital	1987–2007	122	Initial	73.8	Mean dose: 60.38 mg/day (SD 21.21, range 5–120 mg/day)
Kulthanan et al (2011)¹⁶	Thailand	Clinic	1991–2009	58	Initial	89.7	Mean cumulative dose to achieve remission: 0.05 g/kg
Serwin et al (2007)¹⁷	Poland	Hospital, clinic	2000–2005	35	Initial	68.6	Dose range: 40–60 mg/day
Nanda et al (2006)¹⁸	Kuwait	Clinic	1991–2005	41	Initial	100	—
Tan and Tay (2018)¹⁹	Singapore	Hospital	2004–2012	100	Any time	96.0	Mean duration: 11.6 months (range 1 week to 60 months)
Wong and Chua (2002)²⁰	Singapore	Hospital	1998–1999	59	Initial	76.0	Mean dose: 31.2 mg/day (range 15–60 mg/day) when used as monotherapy
Chang et al (1996)²¹	Taiwan	Hospital	1977–1994	86	Initial	83.7	Mean dose: 54.1 mg/day
Garcia-Doval et al (2005)²²	Spain	Hospital	1998–2003	26	Unclear	53.9	Mean daily dose at start of therapy: 34 mg (SD 9.8, range 20–50 mg/day) Mean duration: 20 months (SD 12)

SD = standard deviation.